MediGuide uses a GPS-like technology to track catheters.
A scan in time saves nine?
Contract covers full DR portfolio.
Troubled molecular imaging company considers sale of assets or restructuring.
Money used to research Entolimod.
Health care leads U.S. sectors in hiring.
ZS3 released.
Letter from the online editor - October 2012
What we have here is a failure to communicate, docs say.
Americans don't see the doctor as often, on average, as they did in 2001.
New CEO takes over for interim boss Curt R. Hartman.
MRI makers want the government to hold onto its helium.
McKesson to scoop up third-party billing company.
Voice recognition company beefs up ICD-10 offerings.
Researchers find 3 percent of U.S. hospitals have had a shooting in the past 12 years.
Robert Wood Johnson Foundation exec Dr. John Lumpkin says health reform "isn't going to sink."
Carestream to sell off its line of in-vivo preclinical imaging systems.
Real-world effects?
somo-v ABUS for screening gets FDA nod.
Ultra-cheap ultrasound could help pregnant women in poor countries.
Echelon Oval 1.5T MRI was installed at a Cincinnati imaging center.
Construction on center planned to start next year.
PACS pioneer Dr. Elliot Siegel says artificial intelligence needs to come to medicine.
Where will iPhones and iPads fit into your workflow?
Mayo Clinic gets approval for Choline C 11 injections.
AHRQ touts four-year project's success in reducing central line-bloodstream infections.
Pharma exec on board.
Merge might merge.
Everybody loves Clinton, right?
Hospitals and health systems were better prepared than in 2005, experts say.
Letter from the online editor - September 2012
A plan to pay more for technetium-99 derived from non-weapons-grade uranium might be premature, the AHA and other groups say.
However, a "misconception of lower quality" limits penetration in China, Brazil and Japan.
Multix Fusion digital radiography system goes on sale.
Elekta's biggest deal ever in China.
Bill would stop multiple procedure payment reduction (MPPR) cuts.
5,000 members.
Triad's second in Maryland.
If approved by the FDA, the system could take part of the $1.8 billion neurostimulation device market.
Committee will evaluate evidence that CMS could use for a later coverage decision.
Vets to be offered screening at six unnamed sites.
CMS scales back some requirements, delays attestation date by one year, because of provider concerns.
New Toshiba MRI line cleared.
CMS wraps up a busy week.
From AHIMA to Siemens, groups respond to CMS' final stage 2 MU regs.
Penrith Corp. has expertise in the "miniaturization of ultrasound devices."
Expect sales of DEET to skyrocket.
Thirsty U.S. hospitals are big consumers of water, major fuels, a new EIA report says.
ER docs the most burnt out, Annals of Internal Medicine study says.
Recalls up.
